HOT NEWS
Bayer HealthCare joins forces with Stroke Alliance for Europe » Ahead of the "Move for Health Day" (10 May) and the "European Stroke Day" (14 May), the Stroke Allia...
Sanofi strengthens its French-German partnership » Sanofi (EURONEXT: SAN and NYSE: SNY) announced its involvement in two major Franco-German projects ...
Merck Serono to finance the launch of the EspeRare Foundation » Merck Serono, a division of Merck, Darmstadt, Germany, today announced the launch of the EspeRare Fo...
Bayer HealthCare to broaden strategic alliance with German Cancer Research Cente... » Bayer HealthCare (Bayer) and the German Cancer Research Center (DKFZ) will extend their successful s...
AstraZeneca and Karolinska Institutet to create Integrated Translational Researc... » AstraZeneca and the Swedish medical university Karolinska Institutet announced today their intention...
Innovative cervical screening app launches in UK and Ireland » The new Roche cobas® HPV Test app for iPad, which provides essential information about cervical can...
Roche obtains EU approval for PERJETA, a new personalised treatment for aggressi... » Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Medicines Agency (EMA) has appr...
Novartis receives EU approval for Ilaris® in patients suffering acute gouty art... » Novartis announced that the European Commission (EC) has approved llaris (canakinumab, ACZ885) in th...
Genzyme Receives Company Award from European Organisation for Rare Diseases (EUR... » Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), ahas received a Company Award from EURORDIS...
Bayer supports innovative drug discovery in Europe » Bayer HealthCare initiated and will coordinate a newly founded pan-European consortium, named Europe...
Schering-Plough
Schering-Plough CorporationSchering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer healthcare products. Schering-Plough's vision is to Earn Trust, Every Day with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

Schering-Plough RSS Channel
Title Filter     Display # 
# Article Title Hits
1 Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 11225
2 More than Half of Rheumatoid Arthritis Patients Feel their Disease Controls their Lives 11612
3 Schering-Plough Announces European Filing of SYCREST(R) (asenapine) 11435
4 Schering-Plough announces collaboration with World Health Organization 10957
5 Schering-Plough Research Institute (SPRI) Invests in Early Drug Discovery Technology 12665
6 Schering-Plough Reports Financial Results for 2008 Fourth Quarter, Full Year 11305
7 Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa 10211
8 New Treatment Options for EU Patients with Certain Primary Brain Tumors 10607